Renhe (Group) Development Co., Ltd.
Renhe Pharmaceutical Co., Ltd. is a listed company listed on the Shenzhen Stock Exchange. The company's stock code is: 000650. The company's predecessor is Jiujiang Chemical Fiber Co., Ltd., which was approved by the Jiangxi Provincial People's Government in 1996. On November 18, 1996 , a company officially listed on the Shenzhen Stock Exchange with the approval of the China Securities Regulatory Commission’s Securities Regulatory Commission (1996) No. 318. In 2006, the company implemented a major asset restructuring, divested its original chemical fiber-related assets, and injected pharmaceutical assets. Through multiple share allocations, transfers, targeted share issuances, etc., the company has become Jiangxi Renhe Pharmaceutical Co., Ltd. and Jiangxi Renhe. China Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Co., Ltd., Jiangxi Heli Pharmaceutical Co., Ltd., Jiangxi Kangmei Pharmaceutical Health Products Co., Ltd., Jiangxi Pharmaceutical Durenhe Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., Jiangxi Shining Pharmaceutical Modern pharmaceutical production and operation enterprises of many subsidiaries such as Jiangxi Ji'an Sanli Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Products Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical City Zhangshu Pharmaceutical Co., Ltd. and other subsidiaries. The company's main business: production and sales of traditional Chinese and Western medicines, raw materials and health-related products, including oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, liniments, suppositories, ointments and other dosage-form drugs, as well as Health-related products. The company's main products: Renhe Kelik, Youkadan series, Fuyanjie series, Dahuolou capsules, Shining eye drops, Qinghuo capsules, Zhengwei capsules, etc. Business scope is: Chinese medicinal materials planting; medicinal seedling cultivation; carton production and sales; computer software development; design, production, release, and agency of various domestic advertisements; building materials, machinery and equipment, hardware and electrical and electronic products, chemical products, Wholesale and retail of metal materials, cultural and sports office supplies, department stores. (Except for the above projects that have special provisions in the country). The company has established and consolidated a sales network covering 30 provinces, cities and autonomous regions across the country. The company adheres to the purpose of "serving human health", follows the corporate philosophy of "people-oriented and harmony-oriented", and the business philosophy of "benevolence and harmony, and win-win" and promotes the corporate spirit of "integrity and unity and keeping pace with the times". With the historical expectation of revitalizing the country's medical industry, we will go to the world and the future with new horizons and new ideas.
Renhe (Group) Development Co., Ltd.
Renhe Pharmaceutical Co., Ltd. is a listed company listed on the Shenzhen Stock Exchange. The company's stock code is: 000650. The company's predecessor is Jiujiang Chemical Fiber Co., Ltd., which was approved by the Jiangxi Provincial People's Government in 1996. On November 18, 1996 , a company officially listed on the Shenzhen Stock Exchange with the approval of the China Securities Regulatory Commission’s Securities Regulatory Commission (1996) No. 318. In 2006, the company implemented a major asset restructuring, divested its original chemical fiber-related assets, and injected pharmaceutical assets. Through multiple share allocations, transfers, targeted share issuances, etc., the company has become Jiangxi Renhe Pharmaceutical Co., Ltd. and Jiangxi Renhe. China Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Co., Ltd., Jiangxi Heli Pharmaceutical Co., Ltd., Jiangxi Kangmei Pharmaceutical Health Products Co., Ltd., Jiangxi Pharmaceutical Durenhe Pharmaceutical Co., Ltd., Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd., Jiangxi Shining Pharmaceutical Modern pharmaceutical production and operation enterprises of many subsidiaries such as Jiangxi Ji'an Sanli Pharmaceutical Co., Ltd., Jiangxi Renhe Pharmaceutical Products Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical City Zhangshu Pharmaceutical Co., Ltd. and other subsidiaries. The company's main business: production and sales of traditional Chinese and Western medicines, raw materials and health-related products, including oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, liniments, suppositories, ointments and other dosage-form drugs, as well as Health-related products. The company's main products: Renhe Kelik, Youkadan series, Fuyanjie series, Dahuolou capsules, Shining eye drops, Qinghuo capsules, Zhengwei capsules, etc. Business scope is: Chinese medicinal materials planting; medicinal seedling cultivation; carton production and sales; computer software development; design, production, release, and agency of various domestic advertisements; building materials, machinery and equipment, hardware and electrical and electronic products, chemical products, Wholesale and retail of metal materials, cultural and sports office supplies, department stores. (Except for the above projects that have special provisions in the country). The company has established and consolidated a sales network covering 30 provinces, cities and autonomous regions across the country. The company adheres to the purpose of "serving human health", follows the corporate philosophy of "people-oriented and harmony-oriented", and the business philosophy of "benevolence and harmony, and win-win" and promotes the corporate spirit of "integrity and unity and keeping pace with the times". With the historical expectation of revitalizing the country's medical industry, we will go to the world and the future with new horizons and new ideas.
Zhongjing Wanxi Pharmaceutical Co., Ltd.
Zhongjing Wanxi Pharmaceutical Co., Ltd., which is known for its industry for its "good medicinal materials, only good medicine", mainly produces "Zhongjing" brand Liuwei Dihuang Pills, Xiaoyao Pills, Tianzhi Granules, Taizi Jin Granules and "Yueyueshu" brand dysmenorrhea Chinese patent medicine products represented by Baogeli, covering and medication for andrologics, gynecology, pediatrics and the elderly. Among them, Zhongjing brand Liuwei Dihuang Pills occupy about one-third of the market share of Liuwei Dihuang Pills; Yueyueshu dysmenorrhea is a well-known product for the treatment of dysmenorrhea in women, and Taizi Jin Granules has been rated as a new brand of pediatric medicine. Over the years, the company has taken Zhongjing culture and authentic medicinal materials as the core, adhered to the business philosophy of "highlighting the inheritance and promotion of Zhang Zhongjing's traditional Chinese medicine culture, highlighting the advantages of Chinese medicinal materials resources in 800 miles, highlighting the modernization of Chinese medicine and manufacturing modern Chinese medicine", and adhered to the "left" The social commitment of the old Chinese medicine doctors to reassure the people, and the ancestors to reassure the society and the pharmaceutical concept of "the medicine is good only if the medicine is good." The company has established six major GAP medicinal materials planting bases and primary processing production lines in Xixia, Wuzhi and Wenxian in Henan; Yuexi and Nanling in Anhui ; Pengshan, Sichuan, respectively, and has established six major GAP medicinal materials planting bases and primary processing production lines, realizing the All six medicinal materials of Liuwei Dihuang Pills originated from the new breakthroughs in the GAP base. The company has established a constant temperature, low temperature and room temperature medicinal materials warehouse, adopting storage methods of partitions, varieties, sources and batches; undertakes the Henan Provincial Traditional Chinese Medicine Modernization Engineering Technology Research Center, and set up a postdoctoral research workstation, with "modern technology integrated in traditional Chinese medicine concentrate The national major scientific and technological support platform such as "pill application" ensures that the source of medicinal materials is clear and the consumption of medicines is safe and secure. The company has created Zhang Zhongjing Pharmacy Chain Company, Nanyang Zhang Zhongjing Hospital, Heilongjiang Mohe Zhang Zhongjing Hospital and Health Center, and has built a health industry chain integrating concentrated pharmaceutical agriculture, traditional Chinese medicine industry, traditional Chinese medicine business, traditional Chinese medicine medical care and traditional Chinese medicine health care, from the source of planting to terminal medical care , create and provide high-quality traditional Chinese medicine products and services, improve the quality of life and life, and benefit the health of the people. The company has successively won the titles of "National May 1st Labor Certificate", "Traditional Famous and Excellent Traditional Chinese Patent Medicine Protection and Production Demonstration Base", "National Traditional Chinese Medicine Cultural Propaganda and Education Base", and "National Ecological Culture Demonstration Enterprise".
Zhongjing Wanxi Pharmaceutical Co., Ltd.
Zhongjing Wanxi Pharmaceutical Co., Ltd., which is known for its industry for its "good medicinal materials, only good medicine", mainly produces "Zhongjing" brand Liuwei Dihuang Pills, Xiaoyao Pills, Tianzhi Granules, Taizi Jin Granules and "Yueyueshu" brand dysmenorrhea Chinese patent medicine products represented by Baogeli, covering and medication for andrologics, gynecology, pediatrics and the elderly. Among them, Zhongjing brand Liuwei Dihuang Pills occupy about one-third of the market share of Liuwei Dihuang Pills; Yueyueshu dysmenorrhea is a well-known product for the treatment of dysmenorrhea in women, and Taizi Jin Granules has been rated as a new brand of pediatric medicine. Over the years, the company has taken Zhongjing culture and authentic medicinal materials as the core, adhered to the business philosophy of "highlighting the inheritance and promotion of Zhang Zhongjing's traditional Chinese medicine culture, highlighting the advantages of Chinese medicinal materials resources in 800 miles, highlighting the modernization of Chinese medicine and manufacturing modern Chinese medicine", and adhered to the "left" The social commitment of the old Chinese medicine doctors to reassure the people, and the ancestors to reassure the society and the pharmaceutical concept of "the medicine is good only if the medicine is good." The company has established six major GAP medicinal materials planting bases and primary processing production lines in Xixia, Wuzhi and Wenxian in Henan; Yuexi and Nanling in Anhui ; Pengshan, Sichuan, respectively, and has established six major GAP medicinal materials planting bases and primary processing production lines, realizing the All six medicinal materials of Liuwei Dihuang Pills originated from the new breakthroughs in the GAP base. The company has established a constant temperature, low temperature and room temperature medicinal materials warehouse, adopting storage methods of partitions, varieties, sources and batches; undertakes the Henan Provincial Traditional Chinese Medicine Modernization Engineering Technology Research Center, and set up a postdoctoral research workstation, with "modern technology integrated in traditional Chinese medicine concentrate The national major scientific and technological support platform such as "pill application" ensures that the source of medicinal materials is clear and the consumption of medicines is safe and secure. The company has created Zhang Zhongjing Pharmacy Chain Company, Nanyang Zhang Zhongjing Hospital, Heilongjiang Mohe Zhang Zhongjing Hospital and Health Center, and has built a health industry chain integrating concentrated pharmaceutical agriculture, traditional Chinese medicine industry, traditional Chinese medicine business, traditional Chinese medicine medical care and traditional Chinese medicine health care, from the source of planting to terminal medical care , create and provide high-quality traditional Chinese medicine products and services, improve the quality of life and life, and benefit the health of the people. The company has successively won the titles of "National May 1st Labor Certificate", "Traditional Famous and Excellent Traditional Chinese Patent Medicine Protection and Production Demonstration Base", "National Traditional Chinese Medicine Cultural Propaganda and Education Base", and "National Ecological Culture Demonstration Enterprise".
Shanghai Baolong Pharmaceutical Co., Ltd.
Baolong Pharmaceutical is a pharmaceutical enterprise integrating drug research and development, manufacturing and sales. It owns Shanghai Baolong Pharmaceutical Co., Ltd., Shanghai Baolong Anqing Pharmaceutical Co., Ltd., Shanghai Weier Biopharmaceutical Technology Co., Ltd. and Yancheng Kelly Pharmaceutical Industry Co., Ltd. covers three major fields: chemical medicine, traditional Chinese medicine and biological medicine, and has many well-known brands such as "Shanglong", "Baolongkang", "Kang Siai", "Yan Kexin", and "Xian Kexin". Baolong has a complete chain of raw material production, preparation research and development, and preparation production in the field of chemical medicine. The dosage forms include topical preparations (non-hormonal and hormone ointments, creams, lotions), oral solid preparations (tablets, capsules, granules. agent, dry suspension), oral liquid preparation (oral solution, syrup). Baolong has a complete chain of Chinese medicinal materials cultivation, Chinese herbal medicine production, and Chinese patent medicine production. The dosage forms include oral solid preparations (concentrated pills, big honey pills, water honey pills, water pills, tablets, capsules, granules), oral liquids Preparation (oral liquid, decoction, syrup, mixture, decoction, wine). Baolong has a professional sales team, covering all regions in the country except Hong Kong, Macao, Taiwan and Tibet, and has formed pharmaceutical commerce, urban hospitals (first terminal), urban pharmacies (second terminal), county and below. Terminal (third terminal) four professional promotion teams. In the future, Baolong will adhere to the industrial development concept of "you, you are healthy!", put pressure on yourself and strive for excellence, continuously improve product quality and service levels, and make its own contribution to ensuring patient rehabilitation, promoting industry development, and benefiting human health. !
Shanghai Baolong Pharmaceutical Co., Ltd.
Baolong Pharmaceutical is a pharmaceutical enterprise integrating drug research and development, manufacturing and sales. It owns Shanghai Baolong Pharmaceutical Co., Ltd., Shanghai Baolong Anqing Pharmaceutical Co., Ltd., Shanghai Weier Biopharmaceutical Technology Co., Ltd. and Yancheng Kelly Pharmaceutical Industry Co., Ltd. covers three major fields: chemical medicine, traditional Chinese medicine and biological medicine, and has many well-known brands such as "Shanglong", "Baolongkang", "Kang Siai", "Yan Kexin", and "Xian Kexin". Baolong has a complete chain of raw material production, preparation research and development, and preparation production in the field of chemical medicine. The dosage forms include topical preparations (non-hormonal and hormone ointments, creams, lotions), oral solid preparations (tablets, capsules, granules. agent, dry suspension), oral liquid preparation (oral solution, syrup). Baolong has a complete chain of Chinese medicinal materials cultivation, Chinese herbal medicine production, and Chinese patent medicine production. The dosage forms include oral solid preparations (concentrated pills, big honey pills, water honey pills, water pills, tablets, capsules, granules), oral liquids Preparation (oral liquid, decoction, syrup, mixture, decoction, wine). Baolong has a professional sales team, covering all regions in the country except Hong Kong, Macao, Taiwan and Tibet, and has formed pharmaceutical commerce, urban hospitals (first terminal), urban pharmacies (second terminal), county and below. Terminal (third terminal) four professional promotion teams. In the future, Baolong will adhere to the industrial development concept of "you, you are healthy!", put pressure on yourself and strive for excellence, continuously improve product quality and service levels, and make its own contribution to ensuring patient rehabilitation, promoting industry development, and benefiting human health. !
Yaodu Pharmaceutical Group Co., Ltd.
Pujitang is a registered trademark of Yaodu Pharmaceutical Group Co., Ltd., which was founded in 1993 and has a registered address in Anguo City, Hebei Province. It is a private group mainly engaged in traditional Chinese patent medicines and integrated with traditional Chinese medicine research and development. enterprise. The company is located in Oriental Pharmaceutical City, Anguo City, covering an area of 55,000 square meters and a construction area of 50,000 square meters. It mainly produces 317 varieties of twelve dosage forms, including pills, tablets, capsules, etc., among which the honey pill series is the leading product, and is sold all over the country. The varieties with higher sales include Xuefu Lixiao Tablets, Xuefu Zhuyu Pills, Cold spirit particles (sugar-free type), etc. The company's products have a complete range of Chinese medicine dosage forms and are the main manufacturer of basic medicines in the country. The company has strong technical strength, the production equipment of pill automated production line has advanced domestic level, and the testing instrument has advanced international level. The company has established long-term and stable cooperative relationships with colleges and universities and research institutes, actively carried out independent innovation activities, has obtained 16 invention patents, obtained 37 patents of various types, owned 36 innovative products of Xiaomi Pills, and Qihuang Granules won the national Certificate of new medicines for six categories of traditional Chinese medicine. The company's comprehensive laboratory has passed the assessment of the Laboratory Accreditation Committee (CNAS) of the China Conformity Assessment National Accreditation Committee, and its testing data have been recognized in 56 countries and regions in Europe, the United States and Southeast Asia. The development of Yaodu Group over the past 20 years has written a brilliant chapter in the history of traditional Chinese medicine development, "promoting the culture of Chinese medicine, creating fine products of medicine, and committed to the development goals of modernization, internationalization and scientificization of traditional Chinese medicine", "hard work, The team spirit of unity, hard work, scientific and technological innovation, and pursuit of perfection and the working principle of "striving for excellence and creating good medicines, carefully calculating and reducing consumption, strengthening soldiers and promoting sales, careful management and increasing efficiency", as well as "people-oriented, scientific development", "good quality and efficacy Excellent corporate culture such as "good" has enhanced the competitiveness and self-development ability of enterprises under market conditions, and promoted the development of enterprises.
Yaodu Pharmaceutical Group Co., Ltd.
Pujitang is a registered trademark of Yaodu Pharmaceutical Group Co., Ltd., which was founded in 1993 and has a registered address in Anguo City, Hebei Province. It is a private group mainly engaged in traditional Chinese patent medicines and integrated with traditional Chinese medicine research and development. enterprise. The company is located in Oriental Pharmaceutical City, Anguo City, covering an area of 55,000 square meters and a construction area of 50,000 square meters. It mainly produces 317 varieties of twelve dosage forms, including pills, tablets, capsules, etc., among which the honey pill series is the leading product, and is sold all over the country. The varieties with higher sales include Xuefu Lixiao Tablets, Xuefu Zhuyu Pills, Cold spirit particles (sugar-free type), etc. The company's products have a complete range of Chinese medicine dosage forms and are the main manufacturer of basic medicines in the country. The company has strong technical strength, the production equipment of pill automated production line has advanced domestic level, and the testing instrument has advanced international level. The company has established long-term and stable cooperative relationships with colleges and universities and research institutes, actively carried out independent innovation activities, has obtained 16 invention patents, obtained 37 patents of various types, owned 36 innovative products of Xiaomi Pills, and Qihuang Granules won the national Certificate of new medicines for six categories of traditional Chinese medicine. The company's comprehensive laboratory has passed the assessment of the Laboratory Accreditation Committee (CNAS) of the China Conformity Assessment National Accreditation Committee, and its testing data have been recognized in 56 countries and regions in Europe, the United States and Southeast Asia. The development of Yaodu Group over the past 20 years has written a brilliant chapter in the history of traditional Chinese medicine development, "promoting the culture of Chinese medicine, creating fine products of medicine, and committed to the development goals of modernization, internationalization and scientificization of traditional Chinese medicine", "hard work, The team spirit of unity, hard work, scientific and technological innovation, and pursuit of perfection and the working principle of "striving for excellence and creating good medicines, carefully calculating and reducing consumption, strengthening soldiers and promoting sales, careful management and increasing efficiency", as well as "people-oriented, scientific development", "good quality and efficacy Excellent corporate culture such as "good" has enhanced the competitiveness and self-development ability of enterprises under market conditions, and promoted the development of enterprises.
Lanzhou Foci Pharmaceutical Co., Ltd.
Lanzhou Foci Pharmaceutical Co., Ltd. is an enterprise with a history of nearly a hundred years. It was founded in Shanghai in 1929, moved westward to Lanzhou in 1956, and was first listed on the Shenzhen Stock Exchange in 2011. It is a state-owned listed company. The company has 6 wholly-owned subsidiaries, 1 holding subsidiary and 2 shareholder subsidiaries. There are 467 approved drug production documents, and the drug production line has passed the national drug GMP certification and the Australian TGA organization and the Japanese Ministry of Health, Labor and Welfare. More than 100 Chinese and Western medicine products are produced in 11 dosage forms such as concentrated pills, Dami pills, granules, capsules, tablets, gelatin, etc., and have ginseng and antler Guben Shao pills, compound Astragalus Jianpi oral liquid, bamboo leaves 10 products including pepper flakes. Foci products are well-known both at home and abroad for their authentic materials selection, excellent craftsmanship, accurate efficacy and easy to take. The products are exported to 29 countries and regions including the United States, Canada, Australia, Japan, Brazil, Hong Kong, etc., with the number of product certifications and overseas trademark registrations. , export coverage and export varieties have long been among the top in the same industry. As a high-tech enterprise in Gansu Province, the company has three key R&D platforms: Gansu Province Modern Traditional Chinese Medicine Preparation Engineering Technology Research Center, Gansu Province Traditional Chinese Medicine Quality Control Technology Engineering Laboratory and Provincial Enterprise Technology Center, as well as "Academician Wang Yongyan Expert Workstation" and "Zhang Shichen Expert Team Innovative platforms such as the inheritance base for traditional Chinese medicine preparation techniques. With the vision of "a benchmark enterprise for Chinese traditional medicine quality and the vanguard of revitalizing Long Medicine", the company has established the development strategy of "three-wheel drive" to increase vitality and "six major systems" to promote Long Medicine. Through the three-wheel drive of "operation-driven, innovation-driven, and financial-driven", the company will comprehensively deepen the construction of the "big industry, big market, big production, big brand, big R&D, and big capital" ecological system, and strive to strengthen and expand the manufacturing of Chinese patent medicines. The main business extends the industrial chain and forms a new Foci for the development of the entire industrial chain.
Lanzhou Foci Pharmaceutical Co., Ltd.
Lanzhou Foci Pharmaceutical Co., Ltd. is an enterprise with a history of nearly a hundred years. It was founded in Shanghai in 1929, moved westward to Lanzhou in 1956, and was first listed on the Shenzhen Stock Exchange in 2011. It is a state-owned listed company. The company has 6 wholly-owned subsidiaries, 1 holding subsidiary and 2 shareholder subsidiaries. There are 467 approved drug production documents, and the drug production line has passed the national drug GMP certification and the Australian TGA organization and the Japanese Ministry of Health, Labor and Welfare. More than 100 Chinese and Western medicine products are produced in 11 dosage forms such as concentrated pills, Dami pills, granules, capsules, tablets, gelatin, etc., and have ginseng and antler Guben Shao pills, compound Astragalus Jianpi oral liquid, bamboo leaves 10 products including pepper flakes. Foci products are well-known both at home and abroad for their authentic materials selection, excellent craftsmanship, accurate efficacy and easy to take. The products are exported to 29 countries and regions including the United States, Canada, Australia, Japan, Brazil, Hong Kong, etc., with the number of product certifications and overseas trademark registrations. , export coverage and export varieties have long been among the top in the same industry. As a high-tech enterprise in Gansu Province, the company has three key R&D platforms: Gansu Province Modern Traditional Chinese Medicine Preparation Engineering Technology Research Center, Gansu Province Traditional Chinese Medicine Quality Control Technology Engineering Laboratory and Provincial Enterprise Technology Center, as well as "Academician Wang Yongyan Expert Workstation" and "Zhang Shichen Expert Team Innovative platforms such as the inheritance base for traditional Chinese medicine preparation techniques. With the vision of "a benchmark enterprise for Chinese traditional medicine quality and the vanguard of revitalizing Long Medicine", the company has established the development strategy of "three-wheel drive" to increase vitality and "six major systems" to promote Long Medicine. Through the three-wheel drive of "operation-driven, innovation-driven, and financial-driven", the company will comprehensively deepen the construction of the "big industry, big market, big production, big brand, big R&D, and big capital" ecological system, and strive to strengthen and expand the manufacturing of Chinese patent medicines. The main business extends the industrial chain and forms a new Foci for the development of the entire industrial chain.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. is affiliated to Guangzhou Pharmaceutical Group Co., Ltd. and is a wholly-owned subsidiary of the listed company Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (Baiyunshan 600332). The company is located in Huangpu District, Guangzhou City, covering an area of 120,000 square meters, with a registered capital of 217 million yuan, and has nearly 1,200 employees. The company owns two trademarks "Baiyunshan" and "Zhongyi", and is mainly engaged in the research and development, manufacturing, sales and health services of traditional Chinese patent medicines and big health products. In 1662, the founder Huang Zhonghuang Pharmacy was founded, and during this period, it absorbed and merged several well-known pharmaceutical factories. In June 1956, it merged with the former Baozitang and Chongfoshi and other private factories to form the public-private joint Baozitang Joint Pharmaceutical Factory. After being merged into several companies, it was renamed Guangzhou Traditional Chinese Medicine Factory No. 1 in 1966. Guangzhou Zhongyi Pharmaceutical Co., Ltd. was established in 2002, and was renamed Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. in 2012. The company's development has witnessed the development of traditional Chinese medicine in Lingnan. It has a profound traditional Chinese medicine cultural heritage and can be called the "living fossil" of the development of traditional Chinese medicine in Lingnan. The company has nearly 140 varieties of 6 large dosage forms. The main products are Xiaoxie Pills, Zishen Yufei Pills, Angong Niuhuang Pills, Weinaian Capsules, etc., which are all famous traditional Chinese medicine varieties, becoming the company's resources for inheriting classics and innovative development. treasure house. Xiaoxie Pills are a well-known brand of Chinese patent medicines for oral anti-glycemic drugs in the country. Zishen Yufei Pills are the leading brand of gynecological Chinese patent medicines for fetal care and fetal care drugs. Angong Niuhuang Pills are in a leading position in the same category market. All three varieties are A large variety of traditional Chinese medicine with sales exceeding 100 million yuan. Traditional ancient prescriptions and other traditional ancient prescriptions and medicines such as Angong Niuhuang Pills and Baoying Pills have been passed down as cultural heritages of traditional Chinese medicine to this day. The company has more than 100 patents, and independent innovative products and invention patents account for more than 90% of sales. Standing in the new industry development cycle, Baiyunshan Zhongyi will take the vision of becoming a leader in the traditional Chinese medicine industry, give full play to its advantages, seize opportunities, accelerate the development pace in fashionable traditional Chinese medicine, integrated innovation, industrial upgrading, intelligent manufacturing, etc., and revitalize the brand. New vitality, continuously improve core competitiveness, actively respond to changes in the internal and external environment, seize the new round of development opportunities, reform and leapfrogging, integrate innovation, and achieve high-quality and steady development.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. is affiliated to Guangzhou Pharmaceutical Group Co., Ltd. and is a wholly-owned subsidiary of the listed company Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (Baiyunshan 600332). The company is located in Huangpu District, Guangzhou City, covering an area of 120,000 square meters, with a registered capital of 217 million yuan, and has nearly 1,200 employees. The company owns two trademarks "Baiyunshan" and "Zhongyi", and is mainly engaged in the research and development, manufacturing, sales and health services of traditional Chinese patent medicines and big health products. In 1662, the founder Huang Zhonghuang Pharmacy was founded, and during this period, it absorbed and merged several well-known pharmaceutical factories. In June 1956, it merged with the former Baozitang and Chongfoshi and other private factories to form the public-private joint Baozitang Joint Pharmaceutical Factory. After being merged into several companies, it was renamed Guangzhou Traditional Chinese Medicine Factory No. 1 in 1966. Guangzhou Zhongyi Pharmaceutical Co., Ltd. was established in 2002, and was renamed Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. in 2012. The company's development has witnessed the development of traditional Chinese medicine in Lingnan. It has a profound traditional Chinese medicine cultural heritage and can be called the "living fossil" of the development of traditional Chinese medicine in Lingnan. The company has nearly 140 varieties of 6 large dosage forms. The main products are Xiaoxie Pills, Zishen Yufei Pills, Angong Niuhuang Pills, Weinaian Capsules, etc., which are all famous traditional Chinese medicine varieties, becoming the company's resources for inheriting classics and innovative development. treasure house. Xiaoxie Pills are a well-known brand of Chinese patent medicines for oral anti-glycemic drugs in the country. Zishen Yufei Pills are the leading brand of gynecological Chinese patent medicines for fetal care and fetal care drugs. Angong Niuhuang Pills are in a leading position in the same category market. All three varieties are A large variety of traditional Chinese medicine with sales exceeding 100 million yuan. Traditional ancient prescriptions and other traditional ancient prescriptions and medicines such as Angong Niuhuang Pills and Baoying Pills have been passed down as cultural heritages of traditional Chinese medicine to this day. The company has more than 100 patents, and independent innovative products and invention patents account for more than 90% of sales. Standing in the new industry development cycle, Baiyunshan Zhongyi will take the vision of becoming a leader in the traditional Chinese medicine industry, give full play to its advantages, seize opportunities, accelerate the development pace in fashionable traditional Chinese medicine, integrated innovation, industrial upgrading, intelligent manufacturing, etc., and revitalize the brand. New vitality, continuously improve core competitiveness, actively respond to changes in the internal and external environment, seize the new round of development opportunities, reform and leapfrogging, integrate innovation, and achieve high-quality and steady development.
Lishizhen Medical Group Co., Ltd.
Li Shizhen Pharmaceutical Group was officially established in 2002. It is located in Qichun, Hubei, the hometown of the Medical Saint Li Shizhen. It has now developed into a series of major health products such as the cultivation of authentic medicinal materials, Chinese patent medicines, Chinese herbal medicine tablets, Chinese herbal formula granules, health wine, Qi Ai series of big health products A full-industry chain group company integrating production, R&D, pharmaceutical wholesale and retail, pharmaceutical culture and tourism, moxibustion, massage and other traditional Chinese medicine suitable technical training. The group is a high-tech enterprise in Hubei Province, a pharmaceutical GMP inspector training base in Hubei Province, a college graduate employment internship base in Hubei Province, and a graduate work station in Central China Agricultural University. The group has two major production bases, "Hubei Qichun Compendium Materia Medica Biotechnology Park", "Xiamen Meishang Pharmaceutical Haicang Factory Area", and "Hubei Wuhan Taiwan Biotechnology Industrial Park" (Medical Flow Park), with 8 holding subsidiaries. , has 20 pharmaceutical production dosage forms, 185 national drug approval documents, 23 dosage forms and production license items that have passed the national GMP certification, 22 production workshops, a factory area of 150,000 square meters, and an annual production capacity of 6 billion yuan. Now, more than 100 Chinese patent medicine varieties are mainly produced, of which more than 40 basic medicine varieties can be included in the medical insurance catalog; more than 350 Chinese medicine formula granules are produced; more than 700 authentic Chinese herbal medicine varieties are produced and operated, and more than 100 Qi Ai products are produced. The group takes the Hubei Provincial Traditional Chinese Medicine Resource Application Engineering Technology Research Center awarded by the Hubei Provincial Department of Science and Technology as an innovative research and development platform, and has joined hands with 15 domestic scientific research institutes and universities to carry out extensive cooperation in industry, academia and research to build the company's high-level scientific research platform. There are currently 7 major laboratories, equipped with more than 200 sets of various scientific research facilities and equipment, and nearly 100 technical support personnel engaged in scientific research and R&D. They can conduct trial production of products such as medicines, food, cosmetics, disinfection products, medical devices, and wormwood products. There are more than 1,100 standard formulation, stability inspection and performance testing projects, and a series of scientific research work such as trace detection, molecular structure confirmation, bactericidal ability confirmation, trace element and content analysis and detection can also be carried out. More than 50 million yuan of R&D expenses are invested every year, nearly 10 national and provincial scientific research projects have been approved, more than 30 patents have been obtained, and 8 provincial and municipal scientific and technological progress awards have been won. The developed traditional Chinese medicine formula granules have been included in the production pilot project by Hubei Province. The group has established more than 800 terminal marketing service offices, with sales networks all over the country. The group owns brands such as "Compendium of Materia Medica", "Li Shizhen", "Qi Ai" and "Jia Fang". The group established the production concept of "using authentic medicinal materials and making scientific Chinese medicine", and always regarded the fields as the production workshop of the enterprise, standardized the entire production process from the source, strictly abide by the GAP standards, and established Coptis chinensis, Magnolia officinalis, Sydney, Sichuan shellfish, There are more than 100 mu of authentic medicinal materials bases of more than 100 varieties of Qi Ai and Xia Dust Grass.
Lishizhen Medical Group Co., Ltd.
Li Shizhen Pharmaceutical Group was officially established in 2002. It is located in Qichun, Hubei, the hometown of the Medical Saint Li Shizhen. It has now developed into a series of major health products such as the cultivation of authentic medicinal materials, Chinese patent medicines, Chinese herbal medicine tablets, Chinese herbal formula granules, health wine, Qi Ai series of big health products A full-industry chain group company integrating production, R&D, pharmaceutical wholesale and retail, pharmaceutical culture and tourism, moxibustion, massage and other traditional Chinese medicine suitable technical training. The group is a high-tech enterprise in Hubei Province, a pharmaceutical GMP inspector training base in Hubei Province, a college graduate employment internship base in Hubei Province, and a graduate work station in Central China Agricultural University. The group has two major production bases, "Hubei Qichun Compendium Materia Medica Biotechnology Park", "Xiamen Meishang Pharmaceutical Haicang Factory Area", and "Hubei Wuhan Taiwan Biotechnology Industrial Park" (Medical Flow Park), with 8 holding subsidiaries. , has 20 pharmaceutical production dosage forms, 185 national drug approval documents, 23 dosage forms and production license items that have passed the national GMP certification, 22 production workshops, a factory area of 150,000 square meters, and an annual production capacity of 6 billion yuan. Now, more than 100 Chinese patent medicine varieties are mainly produced, of which more than 40 basic medicine varieties can be included in the medical insurance catalog; more than 350 Chinese medicine formula granules are produced; more than 700 authentic Chinese herbal medicine varieties are produced and operated, and more than 100 Qi Ai products are produced. The group takes the Hubei Provincial Traditional Chinese Medicine Resource Application Engineering Technology Research Center awarded by the Hubei Provincial Department of Science and Technology as an innovative research and development platform, and has joined hands with 15 domestic scientific research institutes and universities to carry out extensive cooperation in industry, academia and research to build the company's high-level scientific research platform. There are currently 7 major laboratories, equipped with more than 200 sets of various scientific research facilities and equipment, and nearly 100 technical support personnel engaged in scientific research and R&D. They can conduct trial production of products such as medicines, food, cosmetics, disinfection products, medical devices, and wormwood products. There are more than 1,100 standard formulation, stability inspection and performance testing projects, and a series of scientific research work such as trace detection, molecular structure confirmation, bactericidal ability confirmation, trace element and content analysis and detection can also be carried out. More than 50 million yuan of R&D expenses are invested every year, nearly 10 national and provincial scientific research projects have been approved, more than 30 patents have been obtained, and 8 provincial and municipal scientific and technological progress awards have been won. The developed traditional Chinese medicine formula granules have been included in the production pilot project by Hubei Province. The group has established more than 800 terminal marketing service offices, with sales networks all over the country. The group owns brands such as "Compendium of Materia Medica", "Li Shizhen", "Qi Ai" and "Jia Fang". The group established the production concept of "using authentic medicinal materials and making scientific Chinese medicine", and always regarded the fields as the production workshop of the enterprise, standardized the entire production process from the source, strictly abide by the GAP standards, and established Coptis chinensis, Magnolia officinalis, Sydney, Sichuan shellfish, There are more than 100 mu of authentic medicinal materials bases of more than 100 varieties of Qi Ai and Xia Dust Grass.
Shanxi Huakang Pharmaceutical Co., Ltd.
Shanxi Huakang Pharmaceutical Co., Ltd. is a modern pure Chinese medicine pharmaceutical enterprise integrating production, marketing, and research and development. The company was founded in 1978 and is located in Chengdong Industrial Park, Wanrong County, Shanxi Province. It has a total area of 250,000 square meters, a building area of 200,000 square meters, and a registered capital of 80 million yuan. The company has an advanced nuclear energy radiation application research center and a modern Chinese medicine technology industrial park in the national pharmaceutical industry, and has a modern digital production line and smart workshop in China. In recent years, the company has actively responded to the "Healthy China" strategy, adhered to quality-based, culture-based, and innovation-based, and continuously improved the modern production level of traditional Chinese medicine, and blazed a path of high-quality development. At present, the company has obtained 3 national invention patents, 25 utility model patents, and 9 appearance design patents. The "Lifei" series of products has a variety of products and reliable quality, covering 5 dosage forms, 12 series and 186 varieties. With its good quality and market reputation, its marketing network is spread across 31 provinces across the country and has been well received by consumers. The production process of Lixiao Dahawthorn Pills is an "intangible cultural heritage". China has been in great prosperity for more than 5,000 years, and China is healthy and the ancestors have hoped for it. Shanxi Huakang Pharmaceutical has always adhered to the sacred mission of "making high-quality Chinese medicine and escorting health", and has taken "promoting the five thousand years of traditional Chinese medicine culture and revitalizing national traditional Chinese medicine enterprises" as its mission, and "caring for life and serving with care" as its service concept. Dedicate your health to the general public and work hard to realize the corporate vision of "vibrant Huakang, harmonious Huakang, happy Huakang, beautiful Huakang, people Huakang, and century-old Huakang"! Integrate Huakang elements into the national actions to promote the development of traditional Chinese medicine and contribute Huakang’s strength!
Shanxi Huakang Pharmaceutical Co., Ltd.
Shanxi Huakang Pharmaceutical Co., Ltd. is a modern pure Chinese medicine pharmaceutical enterprise integrating production, marketing, and research and development. The company was founded in 1978 and is located in Chengdong Industrial Park, Wanrong County, Shanxi Province. It has a total area of 250,000 square meters, a building area of 200,000 square meters, and a registered capital of 80 million yuan. The company has an advanced nuclear energy radiation application research center and a modern Chinese medicine technology industrial park in the national pharmaceutical industry, and has a modern digital production line and smart workshop in China. In recent years, the company has actively responded to the "Healthy China" strategy, adhered to quality-based, culture-based, and innovation-based, and continuously improved the modern production level of traditional Chinese medicine, and blazed a path of high-quality development. At present, the company has obtained 3 national invention patents, 25 utility model patents, and 9 appearance design patents. The "Lifei" series of products has a variety of products and reliable quality, covering 5 dosage forms, 12 series and 186 varieties. With its good quality and market reputation, its marketing network is spread across 31 provinces across the country and has been well received by consumers. The production process of Lixiao Dahawthorn Pills is an "intangible cultural heritage". China has been in great prosperity for more than 5,000 years, and China is healthy and the ancestors have hoped for it. Shanxi Huakang Pharmaceutical has always adhered to the sacred mission of "making high-quality Chinese medicine and escorting health", and has taken "promoting the five thousand years of traditional Chinese medicine culture and revitalizing national traditional Chinese medicine enterprises" as its mission, and "caring for life and serving with care" as its service concept. Dedicate your health to the general public and work hard to realize the corporate vision of "vibrant Huakang, harmonious Huakang, happy Huakang, beautiful Huakang, people Huakang, and century-old Huakang"! Integrate Huakang elements into the national actions to promote the development of traditional Chinese medicine and contribute Huakang’s strength!
Shanxi Tiansheng Pharmaceutical Co., Ltd.
Shanxi Tiansheng Pharmaceutical Co., Ltd. was founded in 1955. It was formerly known as Shanxi Yushe Donkey-hide gelatin factory, which owns 132 national drug-accurate varieties. The company attaches great importance to the natural geographical environment with good product quality and has built a medicinal material planting base. The company has advanced production equipment, production process flow, and a complete quality control and inspection and testing system, which ensures the safety and stability of the quality of drugs. It has a good reputation and a good reputation in the domestic Chinese patent medicine market. Since its establishment, the company has always focused on "taking people's health as its responsibility", upholding the work style of "diligence, down-to-earth, rigorous and meticulous", and constantly exploring and seeking higher goals. The company is confident and is willing to work together with colleagues from all walks of life to make Tiansheng Pharmaceutical a modern, professional, contributing to society and having a certain influence at home and abroad.
Shanxi Tiansheng Pharmaceutical Co., Ltd.
Shanxi Tiansheng Pharmaceutical Co., Ltd. was founded in 1955. It was formerly known as Shanxi Yushe Donkey-hide gelatin factory, which owns 132 national drug-accurate varieties. The company attaches great importance to the natural geographical environment with good product quality and has built a medicinal material planting base. The company has advanced production equipment, production process flow, and a complete quality control and inspection and testing system, which ensures the safety and stability of the quality of drugs. It has a good reputation and a good reputation in the domestic Chinese patent medicine market. Since its establishment, the company has always focused on "taking people's health as its responsibility", upholding the work style of "diligence, down-to-earth, rigorous and meticulous", and constantly exploring and seeking higher goals. The company is confident and is willing to work together with colleagues from all walks of life to make Tiansheng Pharmaceutical a modern, professional, contributing to society and having a certain influence at home and abroad.
Beijing Tong Ren Tang Group Co., Ltd.
A traditional Chinese herbal formula used to tonify the spleen and heart, improve digestion, and enhance overall vitality.
Beijing Tong Ren Tang Group Co., Ltd.
A traditional Chinese herbal formula used to tonify the spleen and heart, improve digestion, and enhance overall vitality.
